Extent of Intrahepatic Infiltration of Perihilar Cholangiocarcinoma
NCT ID: NCT06357117
Last Updated: 2024-04-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
62 participants
OBSERVATIONAL
2018-04-13
2021-12-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Image Driven Hepatocellular Carcinoma Invasiveness Evaluation Research
NCT06559761
Study of Immune Response and Liver Damage Induced by Chemotherapy for Liver Metastases of Colorectal Cancer
NCT01673607
Diagnostic Approach for Cholangiocarcinoma Using Liquid Bile Biopsy
NCT06416397
Integrative Analysis of CRC Liver Metastasis
NCT02917707
Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma
NCT03104569
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No RLI vs RLI
No RLI: PHCC patients without RLI. RLI: PHCC patients with RLI.
No interventions assigned to this group
No DIHI vs DIHI
No DIHI: PHCC patients without DIHI. DIHI: PHCC patients with DIHI.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Hepatectomy was performed.
3. WDLPS was successfully produced.
Exclusion Criteria
2. Patients with PHCC did not undergo hepatectomy.
3. WDLPS was not successfully produced.
44 Years
81 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Tsinghua Chang Gung Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shuo Jin
Attending physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shuo Jin, PhD
Role: PRINCIPAL_INVESTIGATOR
Beijing Tsinghua Changgung Hospital affiliated to Tsinghua University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Tsinghua Chang Gung Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Jin S, Jiang N, Zhao JM, Xiao Y, Wang SY, Xiang CH, Lu Q, Shan SQ, Ruan HT, Yu SQ, Zeng JP, Yang SZ, Li L, Dong JH. Pattern and extent of intrahepatic infiltration of perihilar cholangiocarcinoma - a case-control study based on liver panoramic digital pathology. Int J Surg. 2025 Jan 1;111(1):31-39. doi: 10.1097/JS9.0000000000002040.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A01263
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.